Transdermal delivery of zidovudine (AZT): The effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin
- 386 Downloads
The purpose of this study was to investigate the effects of vehicles, enhancers, and polymer membranes on 3-azido-3-deoxythymidine (AZT) permeation across cadaver pig skin. Four binary vehicles (ethanol/water, isopropyl alcohol/water, polyethylene glycol 400/water, and ethanol/isopropyl myristate [IPM] were tested for AZT solubility and permeability across pig skin; ethanol/IPM (50/50, vol/vol) demonstrated the highest AZT flux (185.23 μ/cm2/h). Next, the addition of various concentrations of different enhancers (N-methyl-2-pyrrolidone [NMP], oleic acid, and lauric acid) to different volume ratios of ethanol/IPM was investigated for their effect on AZT solubility and permeability across pig skin. The use of 2 conbinations (ethanol/IPM [20/80] plus 10% NMP and ethanol/IPM [30/70] plus 10% NMP) resulted in increased AZT solubility (42.6 and 56.27 mg/mL, respectively) and also high AZT flux values (284.92 and 460.34 μg/cm2/h, respectively) without appreciable changes in lag times (6.25 and 7.49 hours, respectively) when compared with formulations using only ethanol/IPM at 20/80 and 30/70 volume ratios without addition of the enhancer NMP. Finally, AZT permeation across pig skin covered with a microporous polyethylene (PE) membrane was investigated. The addition of the PE membrane to the pig skin reduced AZT flux values to ∼50% of that seen with pig skin alone. However, the AZT flux value attained with ethanol/IPM (30/70) plus 10% NMP was 215.30 μg/cm2/h, which was greater than the target flux (208 μg/cm2/h) needed to maintain the steady-state plasma concentration in humans. The results obtained from this study will be helpful in the development of an AZT transdermal drug delivery system.
KeywordsZidovudine permeation enhancer binary vehicles polymer membrane transdermal delivery system
Unable to display preview. Download preview PDF.
- 1.Chien YW, Wearley LL. Aids and chemotherapy.Drugs of Today. 1989;25:19–25.Google Scholar
- 2.Merigan TC, Skowron G. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.Am J Med. 1990;88(suppl 5B):S11-S15.CrossRefGoogle Scholar
- 3.Kieburtz KD, Siedlin M, Lambert JS, et al. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.J Acquir Immune Defic Syndr. 1992;5:60–64.Google Scholar
- 5.Seki T, Toeda C, Kawaguchi T, Juni K, Sugubayashi K, Morimoto Y. Enhanced transdermal delivery of zidovudine in rats and human skin.Chem Pharm Bull (Tokyo). 1990;38:3086–3089.Google Scholar
- 19.Kenneth CJ, ed. Solution and solubioity.Solubility and Related Properties. New York, NY: Marcel Dekker, 1986:37–49.Google Scholar
- 20.Higuchi T, Connors KA. Phase solubility techniques.Adv Anal Chem Instrum. 1965;4:117–212.Google Scholar
- 21.Harrison SM, Barry BW, Dugard PH. Effects of freezing on human skin permeability.J Pharm Pharmacol. 1984;36:261–262.Google Scholar
- 22.Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability.J Pharm Pharmacol. 1992;44:640–645.Google Scholar
- 23.Lieb LM, Nash RA, Matias JR, Orentreich N. A new in vitro method for transepidermal water loss: A possible method for moisturizer evaluation.J Soc Cosmet Chem. 1988;39:107–119.Google Scholar